Search research articles
Contact Us
Filters
Showing results (21-30 of 46) with videos related to
Page
of 5
Sort By:
Frontiers in Medicine
|
July 24, 2025
Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome-a clinical pilot study
Øystein Fluge, Ingrid Gurvin Rekeland, Kari Sørland, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 21, 2018
Consolidative Radiotherapy to Residual Masses After Chemotherapy Is Associated With Improved Outcome in Diffuse Large B-Cell Lymphoma. A Retrospective, Population-Based Study
Øystein Fluge, Bård Mannsåker, Anders Torp, et al.
Plos One
|
September 19, 2022
Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients
Ingrid G Rekeland, Kari Sørland, Ove Bruland, et al.
Plos One
|
November 1, 2011
Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study
Øystein Fluge, Ove Bruland, Kristin Risa, et al.
Translational Psychiatry
|
July 12, 2022
No replication of previously reported association with genetic variants in the T cell receptor alpha (TRA) locus for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
Marthe Ueland, Riad Hajdarevic, Olav Mella, et al.
Plos One
|
July 23, 2024
Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Ingrid G Rekeland, Kari Sørland, Lisbeth Lykke Neteland, et al.
Cancers
|
February 15, 2022
Long-Term Outcome in a Phase II Study of Regional Hyperthermia Added to Preoperative Radiochemotherapy in Locally Advanced and Recurrent Rectal Adenocarcinomas
Baard-Christian Schem, Frank Pfeffer, Martin Anton Ott, et al.
Plos One
|
July 2, 2015
B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment
Øystein Fluge, Kristin Risa, Sigrid Lunde, et al.
Molecular Neurobiology
|
October 10, 2018
Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Oliver P Günther, Jennifer L Gardy, Phillip Stafford, et al.
Brain, Behavior, and Immunity
|
September 25, 2015
Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome
Madlen Loebel, Patricia Grabowski, Harald Heidecke, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 46) with videos related to
Sort By:
Page
of 5
Frontiers in Medicine
|
July 24, 2025
Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome-a clinical pilot study
Øystein Fluge, Ingrid Gurvin Rekeland, Kari Sørland, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 21, 2018
Consolidative Radiotherapy to Residual Masses After Chemotherapy Is Associated With Improved Outcome in Diffuse Large B-Cell Lymphoma. A Retrospective, Population-Based Study
Øystein Fluge, Bård Mannsåker, Anders Torp, et al.
Plos One
|
September 19, 2022
Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients
Ingrid G Rekeland, Kari Sørland, Ove Bruland, et al.
Plos One
|
November 1, 2011
Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study
Øystein Fluge, Ove Bruland, Kristin Risa, et al.
Translational Psychiatry
|
July 12, 2022
No replication of previously reported association with genetic variants in the T cell receptor alpha (TRA) locus for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
Marthe Ueland, Riad Hajdarevic, Olav Mella, et al.
Plos One
|
July 23, 2024
Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Ingrid G Rekeland, Kari Sørland, Lisbeth Lykke Neteland, et al.
Cancers
|
February 15, 2022
Long-Term Outcome in a Phase II Study of Regional Hyperthermia Added to Preoperative Radiochemotherapy in Locally Advanced and Recurrent Rectal Adenocarcinomas
Baard-Christian Schem, Frank Pfeffer, Martin Anton Ott, et al.
Plos One
|
July 2, 2015
B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment
Øystein Fluge, Kristin Risa, Sigrid Lunde, et al.
Molecular Neurobiology
|
October 10, 2018
Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Oliver P Günther, Jennifer L Gardy, Phillip Stafford, et al.
Brain, Behavior, and Immunity
|
September 25, 2015
Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome
Madlen Loebel, Patricia Grabowski, Harald Heidecke, et al.
Page
of 5